Skip to main content

Advertisement

SpringerLink
Log in

Diminution of Circulating CD4+CD25high T Cells in Naïve Crohn’s Disease

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Crohn’s disease is considered to be caused either by an excess of T-cell effector functions and/or by a defective regulatory T-cell compartment. The aim of this study was to assess in Crohn’s disease the frequency of circulating CD4+CD25high T cells that possess regulatory T-cell functions and CD4+CD25low T cells that contain activated T cells. Flow cytometry of peripheral blood was used to assess CD4+CD25high and CD4+CD25low T-cell frequencies in a cohort of 66 patients with Crohn’s disease in comparison to 19 patients with ulcerative colitis and 31 healthy individuals enrolled as controls. The CD4+CD25high T-cell frequency was significantly lowered in naïve Crohn’s disease (P = 0.013) and in ulcerative colitis (P = 0.001). CD4+CD25low T-cell frequency was increased in Crohn’s disease (P = 0.0001) and in ulcerative colitis (P = 0.0002). Both CD4+CD25high and CD4+CD25low T-cell frequencies are altered in naïve Crohn’s disease resulting in an imbalance between both populations and a relative contraction of the CD4+CD25high T-cell population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–429. doi:10.1056/NEJMra020831.

    Article  PubMed  CAS  Google Scholar 

  2. Hugot JP. CARD15/NOD2 mutations in Crohn’s disease. Ann N Y Acad Sci. 2006;1072:9–18. doi:10.1196/annals.1326.011.

    Article  PubMed  CAS  Google Scholar 

  3. Hugot JP. Genetic origin of IBD. Inflamm Bowel Dis. 2004;10:S11–S15. doi:10.1097/00054725-200402001-00003.

    Article  PubMed  Google Scholar 

  4. Strober W, Murray PJ, Kitani A, Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol. 2006;6:9–20. doi:10.1038/nri1747.

    Article  PubMed  CAS  Google Scholar 

  5. Strober W, Kelsall B, Marth T. Oral tolerance. J Clin Immunol. 1998;18:1–30. doi:10.1023/A:1023222003039.

    Article  PubMed  CAS  Google Scholar 

  6. Powrie F, Leach MW, Mauze S, Caddle MB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic inflammation in C B-17 SCID mice. Int Immuno. 1993;5:1461–1471. doi:10.1093/intimm/5.11.1461.

    Article  CAS  Google Scholar 

  7. Powrie F, Correa-Oliveira R, Mauze S, Coffman RL. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med. 1994;179:589–600. doi:10.1084/jem.179.2.589.

    Article  PubMed  CAS  Google Scholar 

  8. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10 deficient mice develop chronic enterocolitis. Cell. 1993;75:263–274. doi:10.1016/0092-8674(93)80068-P.

    Article  PubMed  CAS  Google Scholar 

  9. Gorelik L, Flavell RA. Abrogation of TGF-β signalling in T cells leads to spontaneous differentiation and autoimmune disease. Immunity. 2000;12:171–181. doi:10.1016/S1074-7613(00)80170-3.

    Article  PubMed  CAS  Google Scholar 

  10. Mottet C, Uhlig HH, Powrie F. Cure of colitis by CD4+CD25+ regulatory T cells. J Immunol. 2003;170:3939–3943.

    PubMed  CAS  Google Scholar 

  11. Liu H, Hu B, Xu D, Liew FY. CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-β and CTLA4. J Immunol. 2003;171:5012–5017.

    PubMed  CAS  Google Scholar 

  12. Hollander GA, Simpson SJ, Mizoguchi E, et al. Severe colitis in mice with aberrant thymic selection. Immunity. 1995;3:27–38. doi:10.1016/1074-7613(95)90156-6.

    Article  PubMed  CAS  Google Scholar 

  13. Veltkamp C, Sartor RB, Giese T, et al. Regulatory CD4+CD25+ cells reverse imbalances in the T cell pool of bone marrow transplanted Tgε26 mice leading to the prevention of colitis. Gut. 2005;54:207–214. doi:10.1136/gut.2004.046953.

    Article  PubMed  CAS  Google Scholar 

  14. Baechler-Allan C, Viglietta V, Hafler DA. Human CD4+CD25+ regulatory T cells. Semin Immunol. 2004;16:89–97. doi:10.1016/j.smim.2003.12.005.

    Article  CAS  Google Scholar 

  15. Nagler-Anderson C, Bhan AK, Terhorst C. Control freaks: immune regulatory cells. Nat Immunol. 2004;5:119–122. doi:10.1038/ni0204-119.

    Article  PubMed  CAS  Google Scholar 

  16. Cao D, Malmstrom V, Baechler-Allan C, Hafler D, Klareskog L, Trollmo C. Isolation and functional characterization of regulatory CD25bright CD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol. 2003;33:215–223. doi:10.1002/immu.200390024.

    Article  PubMed  CAS  Google Scholar 

  17. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med. 2001;193:1303–1310. doi:10.1084/jem.193.11.1303.

    Article  PubMed  CAS  Google Scholar 

  18. Ghosh S, Goldin E, Gordon FH, et al. Natalizumab for active Crohn’s disease. N Engl J Med. 2003;348:24–32. doi:10.1056/NEJMoa020732.

    Article  PubMed  CAS  Google Scholar 

  19. Podolsky DK, Lobb R, King N, et al. Attenuation of colitis in the Cotton-top tamarin by anti-α4 integrin monoclonal antibody. J Clin Invest. 1993;92:372–380. doi:10.1172/JCI116575.

    Article  PubMed  CAS  Google Scholar 

  20. Lennard-Jones JE. Definition and diagnosis. In: Skandia International Symposia: Regional enteritis (Crohn’s disease). Stockholm: Nordiska Bokhandlen’s Förlag; 1971:105–112.

  21. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world congress of gastroenterology. Can J Gastroenterol. 2005;19(2):5A–36A.

    Google Scholar 

  22. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br J Med. 1958;2:1041–1048.

    Article  Google Scholar 

  23. Heresbach D, Gicquel-Douabin V, Birebent B, et al. NOD2/CARD15 gene polymorphisms in Crohn’s disease: a genotype-phenotype analysis. Eur J Gastroenterol Hepatol. 2004;16:55–62. doi:10.1097/00042737-200401000-00009.

    Article  PubMed  CAS  Google Scholar 

  24. Maul J, Loddenkemper C, Mundt P, et al. Peripheral and intestinal regulatory CD4+CD25high T cells in inflammatory bowel disease. Gastroenterology. 2005;128:1868–1878. doi:10.1053/j.gastro.2005.03.043.

    Article  PubMed  CAS  Google Scholar 

  25. Ehrenstein MR, Evans JG, Singh A, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med. 2004;200:277–285. doi:10.1084/jem.20040165.

    Article  PubMed  CAS  Google Scholar 

  26. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3:521–533. doi:10.1038/nri1132.

    Article  PubMed  CAS  Google Scholar 

  27. Takahashi M, Nakamura K, Honda K, et al. An inverse correlation of human peripheral blood regulatory T cell frequency with disease activity of ulcerative colitis. Dig Dis Sci. 2006;51:677–686. doi:10.1007/s10620-006-3191-2.

    Article  PubMed  Google Scholar 

  28. Esparza EM, Arch RH. Signaling triggered by glucocorticoid-induced tumor necrosis factor receptor family-related gene: regulation at the interface between regulatory T cells and immune effector cells. Front Biosci. 2006;11:1448–1465. doi:10.2741/1895.

    Article  PubMed  CAS  Google Scholar 

  29. Suarez A, Lopez P, Gomez J, Gutierrez C. Enrichment of CD4+CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheum Dis. 2006;65:1512–1517. doi:10.1136/ard.2005.049924.

    Article  PubMed  CAS  Google Scholar 

  30. Karagiannidis C, Akdis M, Holopainen P, et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol. 2004;114:1425–1433. doi:10.1016/j.jaci.2004.07.014.

    Article  PubMed  CAS  Google Scholar 

  31. Chen X, Oppenheim JJ, Winkler-Pickett RT, Ortaldo JR, Zack Howard OM. Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3+CD4+CD25+ T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur J Immunol. 2006;36:2139–2149. doi:10.1002/eji.200635873.

    Article  PubMed  CAS  Google Scholar 

  32. Nadkarni S, Mauri C, Ehrenstein MR. Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β. J Exp Med. 2007;204:33–39. doi:10.1084/jem.20061531.

    Article  PubMed  CAS  Google Scholar 

  33. Hart AL, Kamm MA, Knight SC, Stagg AJ. Quantitative and functional characteristics of intestinal-homing memory T cells: analysis of Crohn’s disease patients and healthy controls. Clin Exp Immunol. 2004;135:137–145. doi:10.1111/j.1365-2249.2004.02347.x.

    Article  PubMed  CAS  Google Scholar 

  34. Watanabe T, Kitani A, Murray PJ, Strober W. NOD2 is a negative regulator of Toll-like receptor2-mediated T helper type 1 responses. Nat Immunol. 2004;5:800–808. doi:10.1038/ni1092.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Part of this work was financed by the French Centre National de la Recherche Scientifique (CNRS) and supported by the Strasbourg University Hospital.

Author information

Authors and Affiliations

  1. Service d’Hépato-Gastroentérologie et d’Assistance Nutritive, Hôpital de Hautepierre, 67098, Strasbourg Cedex, France

    Patrick Chamouard, Zoe Richert & René Baumann

  2. CNRS UPR9021, Immunologie et Chimie Thérapeutiques, Institut de Biologie Moléculaire et Cellulaire, 15 rue René Descartes, 67000, Strasbourg, France

    Fanny Monneaux, Zoe Richert & Sylviane Muller

  3. Laboratoire de Biochimie et de Biologie Moléculaire, Hôpital de Hautepierre, 67098, Strasbourg Cedex, France

    Anne-Claire Voegeli, Thomas Lavaux, Marie Pierre Gaub & Pierre Oudet

Authors
  1. Patrick Chamouard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fanny Monneaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zoe Richert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anne-Claire Voegeli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thomas Lavaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marie Pierre Gaub
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. René Baumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Pierre Oudet
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sylviane Muller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick Chamouard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chamouard, P., Monneaux, F., Richert, Z. et al. Diminution of Circulating CD4+CD25high T Cells in Naïve Crohn’s Disease. Dig Dis Sci 54, 2084–2093 (2009). https://doi.org/10.1007/s10620-008-0590-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0590-6

Keywords

Search

Navigation